BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 27180980)

  • 21. Involvement of BMPR2 in the protective effect of fluoxetine against monocrotaline-induced endothelial apoptosis in rats.
    Wang Y; Zhang XH; Wang HL
    Can J Physiol Pharmacol; 2011 May; 89(5):345-54. PubMed ID: 21619414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension.
    Vignozzi L; Morelli A; Cellai I; Filippi S; Comeglio P; Sarchielli E; Maneschi E; Vannelli GB; Adorini L; Maggi M
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):277-292. PubMed ID: 27425465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary Artery Hypertension Model in Rats by Monocrotaline Administration.
    Bueno-Beti C; Sassi Y; Hajjar RJ; Hadri L
    Methods Mol Biol; 2018; 1816():233-241. PubMed ID: 29987824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin-converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expression in monocrotaline-induced pulmonary arterial hypertension in rats.
    Kanno S; Wu YJ; Lee PC; Billiar TR; Ho C
    Circulation; 2001 Aug; 104(8):945-50. PubMed ID: 11514384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrogen ameliorates pulmonary hypertension in rats by anti-inflammatory and antioxidant effects.
    Kishimoto Y; Kato T; Ito M; Azuma Y; Fukasawa Y; Ohno K; Kojima S
    J Thorac Cardiovasc Surg; 2015 Sep; 150(3):645-54.e3. PubMed ID: 26095621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble guanylate cyclase stimulator, trans-4-methoxy-β-nitrostyrene, has a beneficial effect in monocrotaline-induced pulmonary arterial hypertension in rats.
    Gonzaga-Costa K; Vasconcelos-Silva AA; Rodrigues-Silva MJ; Rebouça CDSM; Duarte GP; Borges RS; Magalhães PJC; Lahlou S
    Eur J Pharmacol; 2021 Apr; 897():173948. PubMed ID: 33609564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluoxetine protects against monocrotaline-induced pulmonary arterial remodeling by inhibition of hypoxia-inducible factor-1α and vascular endothelial growth factor.
    Han DD; Wang Y; Zhang XH; Liu JR; Wang HL
    Can J Physiol Pharmacol; 2012 Apr; 90(4):445-54. PubMed ID: 22448962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osthole attenuates pulmonary arterial hypertension in monocrotaline‑treated rats.
    Li Y; Wang Y; Li Y; Qian Z; Zhu L; Yang D
    Mol Med Rep; 2017 Sep; 16(3):2823-2829. PubMed ID: 28677726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-dependent therapeutic effects of 2-Methoxyestradiol on Monocrotaline-Induced pulmonary hypertension and vascular remodelling.
    Tofovic SP; Jones T; Petrusevska G
    Prilozi; 2010; 31(1):279-95. PubMed ID: 20693947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic therapeutic effects of 2-methoxyestradiol with either sildenafil or bosentan on amelioration of monocrotaline-induced pulmonary hypertension and vascular remodeling.
    Tofovic SP; Jones TJ; Bilan VP; Jackson EK; Petrusevska G
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):475-83. PubMed ID: 20881615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effects of aloperin on monocroline-induced pulmonary hypertension via regulation of Rho A/Rho kinsase pathway in rats.
    Wu F; Yao W; Yang J; Zhang M; Xu Y; Hao Y; Yan L; Niu Y; Sun T; Yu J; Zhou R
    Biomed Pharmacother; 2017 Nov; 95():1161-1168. PubMed ID: 28926926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of toceranib compared with sorafenib on monocrotaline-induced pulmonary arterial hypertension and cardiopulmonary remodeling in rats.
    Leong ZP; Hikasa Y
    Vascul Pharmacol; 2018 Nov; 110():31-41. PubMed ID: 30071297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Capsaicin pretreatment reversed pulmonary arterial hypertension by alleviating inflammation via p38MAPK pathway.
    Xu Y; Gu Q; Qu C
    Exp Lung Res; 2017 Feb; 43(1):8-18. PubMed ID: 28281854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bortezomib alleviates experimental pulmonary arterial hypertension.
    Kim SY; Lee JH; Huh JW; Kim HJ; Park MK; Ro JY; Oh YM; Lee SD; Lee YS
    Am J Respir Cell Mol Biol; 2012 Nov; 47(5):698-708. PubMed ID: 22842494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation.
    Shi W; Zhai C; Feng W; Wang J; Zhu Y; Li S; Wang Q; Zhang Q; Yan X; Chai L; Liu P; Chen Y; Li M
    Life Sci; 2018 Oct; 210():140-149. PubMed ID: 30179628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
    Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caffeic Acid Phenethyl Ester Rescues Pulmonary Arterial Hypertension through the Inhibition of AKT/ERK-Dependent PDGF/HIF-1α In Vitro and In Vivo.
    Cheng CC; Chi PL; Shen MC; Shu CW; Wann SR; Liu CP; Tseng CJ; Huang WC
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bucindolol attenuates the vascular remodeling of pulmonary arteries by modulating the expression of the endothelin-1 A receptor in rats with pulmonary arterial hypertension.
    de Lima-Seolin BG; Hennemann MM; Fernandes RO; Colombo R; Bonetto JHP; Teixeira RB; Khaper N; Godoy AEG; Litvin IE; Sander da Rosa Araujo A; Schenkel PC; Belló-Klein A
    Biomed Pharmacother; 2018 Mar; 99():704-714. PubMed ID: 29710468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling.
    Liu J; Fang G; Lan C; Qiu C; Yao L; Zhang Q; Hu J; Zhang Y; Yang Y; Zhang Y
    Drug Des Devel Ther; 2024; 18():767-780. PubMed ID: 38495631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adipose-derived stem cells attenuate pulmonary arterial hypertension and ameliorate pulmonary arterial remodeling in monocrotaline-induced pulmonary hypertensive rats.
    Luo L; Lin T; Zheng S; Xie Z; Chen M; Lian G; Xu C; Wang H; Xie L
    Clin Exp Hypertens; 2015; 37(3):241-8. PubMed ID: 25271670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.